1-4 of 4
Lev Silberstein, MD
Close
Sort by
Journal Articles

Angiogenin Is a Niche-Secreted RNase Which Regulates Hematopoietic Regeneration

Lev Silberstein, MD PhD, Kevin Goncalves, PhD, Nicholas Severe, PhD, Guo-fu Hu, PhD, David T. Scadden, MD
Journal: Blood
Blood (2016) 128 (22): 171.
https://doi.org/10.1182/blood.V128.22.171.171
Published: 2016
Journal Articles

Real-Time RT-PCR Analysis of Individual Osteolineage Cells within the Hematopoietic Stem Cell Niche

Lev Silberstein, MD PhD, Masatake Osawa, PhD, Charles Lin, PhD, Peter Kharchenko, PhD, Cristina Lo Celso, PhD, Chiaka Aribeana, David T. Scadden, MD
Journal: Blood
Blood (2011) 118 (21): 2389.
https://doi.org/10.1182/blood.V118.21.2389.2389
Published: 2011
Journal Articles

A Role for SCL in Developing Bone? the SCL +19 Core Enhancer Targets Expression to Cells of Developing Bone, Osteocytes, Chondrocytes and Bone Lining Cells.

Lev Silberstein, MD, John E. Pimanda, MD, PhD, Sandie Piltz, Liz Delaney, Scott Oldham, Asha Kallianpur, MD, Massimo Dominici, MD, Stephen Brandt, MD, Berthold Gottgens, PhD, Anthony Green, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4199.
https://doi.org/10.1182/blood.V104.11.4199.4199
Published: 2004
Journal Articles

An SCL +19 Core Enhancer Targets Three Mesoderm-Derived Cell Lineages - Blood, Endothelium and Smooth Muscle.

Lev Silberstein, MD, Maria Jose Sanchez, PhD, Merav Socolovsky, MD, PhD, Gary J. Hoffman, MD, Sandie Piltz, Mark Bowen, Anthony R. Green, MD, PhD, Berthold Gottgens, PhD
Journal: Blood
Blood (2004) 104 (11): 4200.
https://doi.org/10.1182/blood.V104.11.4200.4200
Published: 2004